Nutra Pharma Corp. filed its 10-K on Feb 05, 2021 for the period ending Dec 31, 2018. In this report its auditor, Rotenberg Meril Solomon Bertiger & Guttilla, P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.